Innovative AI applications are reshaping drug development and biologics characterization. Infinimmune launched GLIMPSE-1, a protein language model trained using human antibody sequences, to optimize antibody properties efficiently. Nicoya Lifesciences expanded capabilities by acquiring Applied Photophysics, integrating complementary biophysical tools including SPR and circular dichroism to enhance biologics analysis. These advances promise to improve drug design, safety profiles, and clinical success rates. Additionally, photonic chips developed at MIT perform wireless signal processing at light speed, offering potential in telecom and medical devices.